Sep 2026· Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease· pp.
e053665
· 0 citations· 77 references
Medicine
TL;DR
This review aims to contextualize the bench-to-bedside translational gap, offering an evidence-based roadmap for clinicians, statisticians, and data scientists to safely harness predictive modeling and ensure meaningful improvements in patient outcomes.
Abstract
Clinical prediction models have progressed from traditional risk scores derived from epidemiological cohorts into sophisticated systems capable of integrating multimodal data, electronic health records, and machine learning approaches. This review provides a clinically focused synthesis of the clinical prediction model lifecycle, outlining their conceptual foundations and methodological evolution across health care settings, with particular emphasis on cardiovascular risk prediction. These predictive frameworks inform both population-level public health strategies and individual clinical decision-making. However, external validation studies frequently reveal a stark discrepancy between statistical performance and real-world implementation, driven by temporal calibration drift, geographic transportability failures, and systemic sociodemographic or sex-based biases. Importantly, clinical prediction models should not be viewed as replacements for randomized trial evidence; instead, they function as vital complementary mechanisms to dissect the heterogeneity of treatment effects and individualize treatment decisions by contextualizing average treatment effects at the bedside. As health care shifts toward data-driven infrastructures, this review aims to contextualize the bench-to-bedside translational gap, offering an evidence-based roadmap for clinicians, statisticians, and data scientists to safely harness predictive modeling and ensure meaningful improvements in patient outcomes.
Despite advances in risk prediction, cardiovascular prevention remains suboptimal, reflecting limitations in model architecture, incomplete integration of contextual determinants, and inadequate translation of risk estimates into clinical practice. This review synthesizes epidemiological, methodological, and health sys...
A. Sposito· Journal of the American Hear...· 0 citations
Cardiovascular risk assessment remains a central challenge in both population-based prevention and high-risk clinical settings. We benchmarked a previously developed mechanistic model of cardiovascular ageing against machine-learning baselines across two distinct cohorts and evaluated both discrimination and probabilit...
M. Suleimenova, R. Amanova, Arailym Keneskanova· BioMedInformatics· 0 citations
Future work should prioritize calibration, robustness, transportability, fairness, interpretability, regulatory clarity, workflow integration, and prospective evidence of decision impact or post-deployment benefit, as well as major barriers remain.
Rui-Feng Liu, Ross Arena, V. Vasile et al.· Progress in cardiovascular d...· 0 citations
Accurate primary-prevention risk stratification for coronary artery disease (CAD) remains challenging. We developed and internally validated a framework integrating clinical variables with a polygenic risk score (PRS).
This three-center retrospective cohort included 2,067 adults without baseline CAD. The pri...
F. Lei, Xiang-Wen Xi, Zi-He Dang et al.· Frontiers in Cardiovascular...· 0 citations
For most diseases, whether PRS improves prediction beyond clinical data remains unknown, as existing evidence is concentrated in a handful of conditions with established risk models. Using 900,000 participants from UK Biobank and FinnGen, we developed and validated models for predicting 150 diseases and all-cause morta...
D. Usoltsev, I. Molotkov, N. Kolosov et al.· medRxiv· 0 citations
. Cardiovascular disease remains a significant global health burden, making it crucial to construct accurate risk prediction models. Analyzing a large clinical dataset, this study evaluates the performance of logistic regression and random forest models in predicting cardiovascular and cerebrovascular diseases. Data ar...
Ke-Liang Li· Proceedings of the 4th Inter...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.